Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis

EASL Clinical Practice Guidelines: management of cholestatic liver diseases

European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729 · see citing works

Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease

Smit, J., Schinkel, A. H., Elferink, R. P. J. O., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van ROON, M. A., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90380-9 · Cited by 1,443 · see citing works

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870 · see citing works

Lysyl oxidase: Properties, regulation and multiple functions in biology

Smith‐Mungo, L. I., & Kagan, H. M. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90012-9 · Cited by 581 · see citing works

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R. G. E., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468 · see citing works

A New Xenobiotic-Induced Mouse Model of Sclerosing Cholangitis and Biliary Fibrosis

Fickert, P., Stöger, U., Fuchsbichler, A., Moustafa, T., Marschall, H., Weiglein, A. H., Tsybrovskyy, O., Jaeschke, H., Zatloukal, K., Denk, H., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061133 · Cited by 376 · see citing works

Ursodeoxycholic acid aggravates bile infarcts in bile duct–ligated and Mdr2 knockout mice via disruption of cholangioles

Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Weiglein, A. H., Lammert, F., Marschall, H., Tsybrovskyy, O., Zatloukal, K., Denk, H., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35948 · Cited by 312 · see citing works

24-norUrsodeoxycholic Acid Is Superior to Ursodeoxycholic Acid in the Treatment of Sclerosing Cholangitis in Mdr2 (Abcb4) Knockout Mice

Fickert, P., Wagner, M., Marschall, H., Fuchsbichler, A., Zollner, G., Tsybrovskyy, O., Zatloukal, K., Liu, J., Waalkes, M. P., Cover, C., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.018 · Cited by 301 · see citing works

Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal

Ikenaga, N., Peng, Z., Vaid, K. A., Liu, S. B., Yoshida, S., Sverdlov, D., Mikels, A. J., Smith, V., Schuppan, D., & Popov, Y. V. (2017) · Gut · doi:10.1136/gutjnl-2016-312473 · Cited by 298 · see citing works

Mutations in TJP2 cause progressive cholestatic liver disease

Sambrotta, M., Strautnieks, S. S., Papouli, E., Rushton, P., Clark, B. E., Parry, D. A., Logan, C. V., Newbury, L. J., Kamath, B. M., Ling, S. C., et al. (2014) · Nature Genetics · doi:10.1038/ng.2918 · Cited by 295 · see citing works

Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation

Raimondi, F., Santoro, P., Barone, M. V., Pappacoda, S., Barretta, M. L., Nanayakkara, M., Apicella, C., Capasso, L., & Paludetto, R. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00043.2007 · Cited by 286 · see citing works

Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes

Popov, Y. V., Patsenker, E., Fickert, P., Trauner, M. A., & Schuppan, D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.025 · Cited by 268 · see citing works

Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice

Wagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O., Zatloukal, K., Guo, G. L., Schuetz, J. D., Gonzalez, F. J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01068-0 · Cited by 264 · see citing works

LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution

Barker, H. E., Chang, J., Cox, T. R., Lang, G., Bird, D., Nicolau, M. M., Evans, H., Gartland, A., & Erler, J. T. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2868 · Cited by 253 · see citing works

The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia

Schietke, R. E., Warnecke, C., Wacker, I., Schödel, J., Mole, D. R., Câmpean, V., Amann, K., Goppelt‐Struebe, M., Behrens, J., Eckardt, K., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042424 · Cited by 253 · see citing works

Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis

Tabibian, J. H., O'Hara, S. P., Splinter, P. L., Trussoni, C. E., & LaRusso, N. F. (2014) · Hepatology · doi:10.1002/hep.26993 · Cited by 241 · see citing works

Physiology of bile secretion

Esteller, A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5641 · Cited by 235 · see citing works

The Cholangiopathies

Lazaridis, K. N., & LaRusso, N. F. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.017 · Cited by 216 · see citing works

Biliary bile acids in hepatobiliary injury – What is the link?

Fickert, P., & Wagner, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.026 · Cited by 187 · see citing works

Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury

Perepelyuk, M., Terajima, M., Wang, A. Y., Georges, P. C., Janmey, P. A., Yamauchi, M., & Wells, R. G. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00222.2012 · Cited by 184 · see citing works

Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2

Vadasz, Z., Kessler, O., Akiri, G., Gengrinovitch, S., Kagan, H. M., Baruch, Y., Izhak, O. B., & Neufeld, G. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.052 · Cited by 182 · see citing works

The Pro-regions of Lysyl Oxidase and Lysyl Oxidase-like 1 Are Required for Deposition onto Elastic Fibers

Thomassin, L., WERNECK, C. C., Broekelmann, T. J., Gleyzal, C., Hornstra, I. K., Mecham, R. P., & Sommer, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506832200 · Cited by 144 · see citing works

Functional Anatomy of Normal Bile Ducts

Strazzabosco, M., & Fabris, L. (2008) · The Anatomical Record · doi:10.1002/ar.20664 · Cited by 140 · see citing works

Cholangiocyte anion exchange and biliary bicarbonate excretion

Bañales, J. M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i22.3496 · Cited by 132 · see citing works

Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis

Nakagawa, H., Hikiba, Y., Hirata, Y., Font-Burgada, J., Sakamoto, K., Hayakawa, Y., Taniguchi, K., Umemura, A., Kinoshita, H., Sakitani, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322731111 · Cited by 132 · see citing works

Alterations in Tight Junctions Differ Between Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

Sakisaka, S., Kawaguchi, T., Taniguchi, E., Hanada, S., Sasatomi, K., Koga, H., Harada, M., Kimura, R., Sata, M., Sawada, N., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.25086 · Cited by 106 · see citing works

Pathophysiology of the intrahepatic biliary epithelium

Strazzabosco, M., Spirlı̀, C., & Okolicsànyi, L. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02091.x · Cited by 98 · see citing works

Claudin 2 Deficiency Reduces Bile Flow and Increases Susceptibility to Cholesterol Gallstone Disease in Mice

Matsumoto, K., Imasato, M., Yamazaki, Y., Tanaka, H., 渡辺, 光., Eguchi, H., Nagano, H., Hikita, H., Tatsumi, T., Takehara, T., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.033 · Cited by 94 · see citing works

The LOXL2 Gene Encodes a New Lysyl Oxidase-like Protein and Is Expressed at High Levels in Reproductive Tissues

Saux, C. J., Tronecker, H., Bogić, L., Bryant‐Greenwood, G. D., Boyd, C. D., & Csiszár, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12939 · Cited by 94 · see citing works

Switching On-Off Snail: LOXL2 Versus GSK3?

Peinado, H., Portillo, F., & Cano, A. (2005) · Cell Cycle · doi:10.4161/cc.4.12.2224 · Cited by 79 · see citing works

Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat.

Siegel, R. C., Chen, K. H., Greenspan, J. S., & Aguiar, J. M. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2945 · Cited by 77 · see citing works

Bile duct epithelial tight junctions and barrier function

Rao, R., & Samak, G. (2013) · Tissue Barriers · doi:10.4161/tisb.25718 · Cited by 76 · see citing works

Pathology and Immunopathology of Primary Biliary Cirrhosis With Emphasis On Bile Duct Lesions: Recent Progress

Nakanuma, Y., Tsuneyama, K., Gershwin, M. E., & Yasoshima, M. (1995) · Seminars in Liver Disease · doi:10.1055/s-2007-1007284 · Cited by 65 · see citing works

Localization of the 7H6 Antigen at Tight Junctions Correlates with the Paracellular Barrier Function of MDCK Cells

Zhong, Y., Enomoto, K., Isomura, H., Sawada, N., Minase, T., Oyamada, M., Konishi, Y., & Mori, M. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1299 · Cited by 56 · see citing works

Mitochondrial dysfunction in cholestatic liver diseases

Sastre, J. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e539 · Cited by 56 · see citing works

Regulation of intrahepatic biliary duct morphogenesis by Claudin 15-like b

Cheung, I. D., Bagnat, M., Ma, T. P., Datta, A., Evason, K. J., Moore, J. C., Lawson, N. D., Mostov, K. E., Moens, C. B., & Stainier, D. Y. R. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.10.004 · Cited by 55 · see citing works

Mitochondrial dysfunction in cholestatic liver diseases

Arduini, A. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/539 · Cited by 52 · see citing works

Loss of α-catenin elicits a cholestatic response and impairs liver regeneration

Herr, K. J., Tsang, Y. N., Ong, J., Li, Q., Yap, L. L., Yu, W., Yin, H., Bogorad, R. L., Dahlman, J. E., Chan, Y. G., et al. (2014) · Scientific Reports · doi:10.1038/srep06835 · Cited by 40 · see citing works

Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers ofAbcb4(−/ − ) mice harbouring chronic cholangitis

Nakken, K. E., Nygård, S., Haaland, T., Berge, K. E., Arnkværn, K., Ødegaard, A., Labori, K. J., & Ræder, M. G. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701320521 · Cited by 36 · see citing works

Effect of DL-penicillamine on the aorta of growing chickens. Ultrastructural and biochemical studies.

Ronchetti, I. P., Fornieri, C., Contri, M. B., Quaglino, D., & Caselgrandi, E. (1986) · PubMed Central · Cited by 13 · see citing works

Cholestatic potentials of α-naphthylisothiocyanate (anit) and β-naphthylisothiocyanate (bnit) in the isolated perfused rat liver

Kossor, D. C., Handler, J. A., Dulik, D. M., Meunier, P. C., Leonard, T. B., & Goldstein, R. S. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90648-g · Cited by 12 · see citing works

Novel therapeutic targets for cholestatic and fatty liver disease

Trauner, M., & Fuchs, C. D. (2022) · Gut · doi:10.1136/gutjnl-2021-324305 · Cited by 204 · see citing works

Metal-organic frameworks-based nanozymes for combined cancer therapy

Ding, S., He, L., Bian, X., & Tian, G. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100920 · Cited by 154 · see citing works

Heterogeneity and Function of Kupffer Cells in Liver Injury

Li, W., Chang, N., & Li, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940867 · Cited by 102 · see citing works

Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway

Cheng, F., Yang, F., Wang, Y., Zhou, J., Qian, H., & Yan, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01942-y · Cited by 94 · see citing works

Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities

Vesterhus, M. N., & Karlsen, T. H. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01681-z · Cited by 80 · see citing works

Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3

Findlay, A. D., Foot, J. S., Buson, A., Deodhar, M., Jarnicki, A., Hansbro, P. M., Liu, G., Schilter, H. C., Turner, C. I., Zhou, W., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01283 · Cited by 59 · see citing works

Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases†

Nevens, F., Trauner, M. A., & Manns, M. P. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.10.007 · Cited by 51 · see citing works

Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update

Chew, N., Ng, C. H., Truong, E., Noureddin, M., & Kowdley, K. V. (2022) · Seminars in Liver Disease · doi:10.1055/a-1877-9656 · Cited by 43 · see citing works

Liver Matrix in Benign and Malignant Biliary Tract Disease

Fabris, L., Cadamuro, M., Cagnin, S., Strazzabosco, M., & Gores, G. J. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1705109 · Cited by 30 · see citing works

LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression

Jiao, J.-W., Zhan, X.-H., Wang, J.-J., He, L.-X., Guo, Z., Xu, X., Liao, L., Huang, X., Wen, B., Xu, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102496 · Cited by 30 · see citing works

Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer

Nakagawa, H., Hayata, Y., Yamada, T., Kawamura, S., Suzuki, N., & Koike, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061745 · Cited by 26 · see citing works

Lysyl Oxidase Like‐2 (LOXL2): An Emerging Oncology Target

Chopra, V., Sangarappillai, R. M., Romero‐Canelón, I., & Jones, A. M. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900119 · Cited by 25 · see citing works

The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Lynch, K. D., Keshav, S., & Chapman, R. W. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00456-2 · Cited by 22 · see citing works

Mesenchymal stem cell-derived exosomes as cell-free therapeutics: mechanistic insights and engineering strategies for liver disease treatment

Yu, S., Kong, D., Lu, B., Pan, Y., Zeng, Z., Fu, Y., Zhao, Z., He, K., Tang, R., & Xia, Q. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04747-y · Cited by 22 · see citing works

Is This the Last Requiem for Simtuzumab?

Fickert, P. (2018) · Hepatology · doi:10.1002/hep.30309 · Cited by 19 · see citing works

Advances in the treatment of liver injury based on mesenchymal stem cell-derived exosomes

Hu, C., & Wang, L. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04087-3 · Cited by 18 · see citing works

Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease

Kim, Y. S., Hurley, E., Park, Y., & Ko, S. (2023) · Intestinal Research · doi:10.5217/ir.2023.00039 · Cited by 17 · see citing works

Cell-matrix interactions control biliary organoid polarity, architecture, and differentiation

Fiorotto, R., Mariotti, V., Taleb, S. A., Zehra, S. A., Nguyen, M. T., Amenduni, M., & Strazzabosco, M. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000094 · Cited by 14 · see citing works

Cellular senescence and tumor promotion: Role of the Unfolded Protein Response.

Pluquet, O., & Abbadie, C. (2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.01.001 · Cited by 8 · see citing works

Modulating intestinal barrier function by sphingosine-1-phosphate receptor 1 specific agonist SEW2871 attenuated ANIT-induced cholestatic hepatitis via the gut-liver axis

Yang, T., Li, L., Pang, J., Cai, H., Wei, C., Wang, X., Xia, Z., Huang, X., Zhang, L., & Jiang, Z. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111150 · Cited by 10 · see citing works

Future Medical Treatment of PSC

Krones, E., Marschall, H., & Fickert, P. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00454-4 · Cited by 9 · see citing works

Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression

Laschtowitz, A., Lindberg, E. L., Liebhoff, A.-M., Liebig, L. A., Casar, C., Steinmann, S., Guillot, A., Xu, J., Schwinge, D., Trauner, M. A., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101267 · Cited by 8 · see citing works

Revisiting an Expression Dataset of Discordant Inflammatory Bowel Disease Twin Pairs Using a Mutation Burden Test Reveals CYP2C18 as a Novel Marker

Du, J., Yin, J., Du, H., & Zhang, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.680125 · Cited by 9 · see citing works

Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy

Puente, Á., Fortea, J. I., Posadas, M., García-Blanco, A., Rasines, L., Cabezas, J., Arias, M., Llerena, S., Iruzubieta, P., Fábrega, E., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081242 · Cited by 7 · see citing works

An overview of recent treatment options for primary sclerosing cholangitis

Mousavere, I. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0834 · Cited by 6 · see citing works

Impact of heterogeneity in liver matrix and intrahepatic cells on the progression of hepatic fibrosis

Sun, Z., & Chen, G. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102559 · Cited by 7 · see citing works

Lysyl oxidase like protein-2 (LOXL-2); a novel marker for prediction of intrahepatic cholestasis of pregnancy

Turhan, U., Şahin, B., & Dağ, İ. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1885646 · Cited by 3 · see citing works

Effect of preoperative biliary drainage on cholestasis-associated inflammatory and fibrotic gene signatures in perihilar cholangiocarcinoma

Reiniers, M. J., de Haan, L. R., Weijer, R., Wiggers, J. K., Jongejan, A., Moerland, P. D., Alles, L. K., van Kampen, A. H. C., van Gulik, T. M., Heger, M., et al. (2018) · British journal of surgery · doi:10.1002/bjs.11022 · Cited by 3 · see citing works

Protocol for fabricating a vascularized bile duct-on-a-chip

Song, C., Zhu, M., Wells, R. G., & Du, Y. L. (2025) · Biophysics Reports · doi:10.52601/bpr.2025.240069 · Cited by 2 · see citing works

Pathophysiologic Basis for Alternative Therapies for Cholestasis

Fuchs, C. D., Halilbasic, E., & Trauner, M. A. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch30 · Cited by 2 · see citing works

Liver Macrophages in the Pathogenesis of Viral Hepatitis

Tsomidis, I., Tsakou, A., Voumvouraki, A., & Kouroumalis, E. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070687 · Cited by 2 · see citing works

Primary sclerosing cholangitis

Ahmad, J., & Grewal, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26710-9.00019-5 · Cited by 1 · see citing works

Progressionshemmung der primär sklerosierenden Cholangitis

Lutz, H. H., & Tischendorf, J. J. W. (2019) · Gastro-News · doi:10.1007/s15036-019-0595-3

Additional file 2 of Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway

Cheng, F., Yang, F., Wang, Y., Zhou, J., Qian, H., & Yan, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23536095

Additional file 3 of Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway

Cheng, F., Yang, F., Wang, Y., Zhou, J., Qian, H., & Yan, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23536098

Additional file 1 of Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway

Cheng, F., Yang, F., Wang, Y., Zhou, J., Qian, H., & Yan, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23536092

Additional file 4 of Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway

Cheng, F., Yang, F., Wang, Y., Zhou, J., Qian, H., & Yan, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23536101

BindingDB Entry 50007042: Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.

BindingDB (2021) · UC San Diego · doi:10.7270/q2vm4gj2

Antifibrotic therapy in MASLD: fibrosis reversal and HCC prevention

Roeb, E., & Weiskirchen, R. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2026.90

696 BILE SALTS REGULATE THEIR SYNTHESIS BY INDUCING NITRIC OXIDE (NO) PRODUCTION IN HEPATOCYTES ALLOWING NITROSYLATION AND FUNCTIONALITY OF Cyp7a1 REPRESSOR COMPLEX PROTEINS

Rodríguez‐Ortigosa, C. M., Celay, J., Juanarena, N., Arcelus, S., Medina, J. F., & Prieto, J. (2013) · Journal of Hepatology · doi:10.1016/s0168-8278(13)60698-4 · Cited by 1 · see citing works

695 THREE-DIMENSIONAL RECONSTRUCTION OF THE ARCHITECTURE OF THE BILIARY TREE DURING CHOLESTASIS

Richter, B., Dirsch, O., Gremse, F., Zarafina, S., Kiessling, F. M., Settmacher, U., & Dahmen, U. (2013) · Journal of Hepatology · doi:10.1016/s0168-8278(13)60697-2

Hepatic expression of lysyl oxidase-like-2 ( LOXL2) in primary sclerosing cholangitis (PSC)

French, D. M., Huntzicker, E. G., Goodman, Z. D., Shea, P. R., Ding, D., Rea., S., Smith, V. D., Subramanian, M. P., Levy, C. E., Bowlus, C. L., et al. (2016) · Hepatology · Cited by 3 · see citing works

694 LYSYL OXIDASE-LIKE 2 (LOXL2) PROTEIN IS INDUCED IN HUMAN CHOLESTATIC LIVER DISEASE AND IN ANIMAL MODELS OF CHOLANGIOPATHIES

Pollheimer, M. J., Bowlus, C. L., Lackner, C., Karlsen, T. H., Hov, J. R., Lyman, S. K., Adamkewicz, J. I., Mikels, A. J., Marshall, D. C. L., Smith, V., et al. (2013) · Journal of Hepatology · doi:10.1016/s0168-8278(13)60696-0

Lipocalin‐2 Stimulates Proliferation and a Profibrotic Cholangiocyte Phenotype during Cholestasis

O’Brien, A., Stiles, D., White, T. K., Lopez, M. R., Little, A., Childs, J., Douthitt, A. J., Phan, T., Medford, A., Chen, L., et al. (2022) · The FASEB Journal · doi:10.1096/fasebj.2022.36.s1.r5479